ERBB2 and breast cancer: In general, the association between PL-FAs and BC risk by pathological subtype was similar to that observed for total BC risk (Table 4), although the associations with HER2+ tumors and TN tumors failed to attain statistical significance, probably due to the smaller number of cases.